Novo Nordisk A/S (NVO)
62.16
+2.84
(+4.79%)
USD |
NYSE |
Jan 22, 10:43
Novo Nordisk Price: 62.16 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 220.14 |
| Evaxion AS | 4.31 |
| Regeneron Pharmaceuticals, Inc. | 756.40 |
| Omeros Corp. | 12.44 |
| Viking Therapeutics, Inc. | 34.23 |
Price Related Metrics
| PE Ratio | 18.11 |
| PS Ratio | 5.931 |
| PEG Ratio | 1.599 |
| Price to Book Value | 13.62 |
| Price to Free Cash Flow | 29.95 |
| Earnings Yield | 5.52% |
| Market Cap | 276.21B |
| PEGY Ratio | 1.272 |
| Operating PE Ratio | 13.98 |
| Normalized PE Ratio | 18.11 |